Enliven Therapeutics Stock Forecast - Downside Variance

ELVN Stock   21.68  0.18  0.84%   
Enliven Stock Forecast is based on your current time horizon. Although Enliven Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Enliven Therapeutics' systematic risk associated with finding meaningful patterns of Enliven Therapeutics fundamentals over time.
  
As of the 16th of February 2025, Payables Turnover is likely to grow to 0.53. As of the 16th of February 2025, Common Stock Shares Outstanding is likely to grow to about 42.9 M, while Net Loss is likely to drop (23.4 M).
Enliven Therapeutics has current Downside Variance of 0.
Check Enliven Therapeutics VolatilityBacktest Enliven TherapeuticsInformation Ratio  

Enliven Therapeutics Trading Date Momentum

On February 16 2025 Enliven Therapeutics was traded for  21.68  at the closing time. The top price for the day was 22.38  and the lowest listed price was  21.17 . There was no trading activity during the period 0.0. Lack of trading volume on February 16, 2025 did not affect price variability. The overall trading delta against the current closing price is 0.18% .
Compare Enliven Therapeutics to competition

Other Forecasting Options for Enliven Therapeutics

For every potential investor in Enliven, whether a beginner or expert, Enliven Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enliven Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enliven. Basic forecasting techniques help filter out the noise by identifying Enliven Therapeutics' price trends.

View Enliven Therapeutics Related Equities

 Risk & Return  Correlation

Enliven Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Enliven Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Enliven Therapeutics' current price.

Enliven Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Enliven Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enliven Therapeutics shares will generate the highest return on investment. By undertsting and applying Enliven Therapeutics stock market strength indicators, traders can identify Enliven Therapeutics entry and exit signals to maximize returns.

Enliven Therapeutics Risk Indicators

The analysis of Enliven Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enliven Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enliven stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Enliven Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enliven Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enliven Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enliven Therapeutics Stock:
Check out Historical Fundamental Analysis of Enliven Therapeutics to cross-verify your projections.
To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enliven Therapeutics. If investors know Enliven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enliven Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.89)
Return On Assets
(0.21)
Return On Equity
(0.31)
The market value of Enliven Therapeutics is measured differently than its book value, which is the value of Enliven that is recorded on the company's balance sheet. Investors also form their own opinion of Enliven Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enliven Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enliven Therapeutics' market value can be influenced by many factors that don't directly affect Enliven Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enliven Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enliven Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enliven Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.